Currently, Ian C. Mortimer occupies the position of Chairman for Appili Therapeutics, Inc. and President, Chief Executive Officer & Director at Xenon Pharmaceuticals, Inc., President, Treasurer & Director at Xenon Pharmaceuticals USA, Inc. (a subsidiary of Xenon Pharmaceuticals, Inc.). Mr. Mortimer is also on the board of Perimeter Medical Imaging, Inc. and Perimeter Medical Imaging AI, Inc.

In the past Ian C. Mortimer occupied the position of Chief Financial Officer & Executive Vice President for Arbutus Biopharma Corp.

He received an undergraduate degree from the University of British Columbia and an MBA from Queen's University.